Carlsmed, Inc. (CARL) stock
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.37−0.37 (-2.09%)
Close on Nov 18, 2026Market cap $474.25MP/E –Yield –
Carlsmed operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Carlsmed's operating income for the twelve months ending Jun 30, 2026 was -$38.67M. For fiscal 2025 it was -$30.57M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$30.57M | – |
| FY2024 | Dec 31, 2024 | -$24.12M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$11.04M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.28M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.32M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.04M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.50M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.72M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.70M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.78M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.32M | – |
See a number that looks wrong?